This $975,680.21 prime contract was awarded by the Department of the Army Medical Command to ROCCOR, LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract is for the development of a "supersaturated oxygen emulsion for topical treatment of ocular trauma."
The prime contractor, ROCCOR, LLC, has subcontracted work to the Schepens Eye Research Institute, a non-profit research organization, and the University of Colorado-Denver, a public research university, to support research and development activities. This includes evaluating the efficacy of the supersaturated oxygen emulsion in a mouse model of corneal injury, as well as overseeing the production of emulsion solutions for clinical trials. An additional subcontractor, Oxygen Emulsion Co, LLC, is providing manufacturing support.
The contract has a set-aside designation for total small business participation. It is part of the Army's SBIR program, which funds research and development of innovative technologies to address military needs.
Generated 3/21/24, 10:06 PM